Fluorometric microassays for the determination of cathepsin L and cathepsin S activities in tissue extracts

Biological Chemistry

Volumn 380, Issue 9, 1999, Pages 1109-1116

  Werle, Bernd ^a,b   Staib, Alexander ^a   Jülke, Britta ^a   Ebert, Werner ^a   Zladoidsky, Pavel ^c   Sekirnik, Andreja ^d   Kos, Janko ^d,e   Spiess, Eberhard ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c Drug Research Institute   (Slovakia)

^d JO EF STEFAN INSTITUTE   (Slovenia)

^e KRKA D D   (Slovenia)

Author keywords

Cathepsin S; Cysteine cathepsins; Kinetic assay; Lung cancer

Indexed keywords

CATHEPSIN B; CATHEPSIN L; CATHEPSIN S; CYSTEINE;

ACCURACY; ARTICLE; ASSAY; BODY FLUID; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME KINETICS; FLUOROMETRY; HUMAN; HUMAN TISSUE; LUNG CANCER; PRIORITY JOURNAL; PROTEIN STABILITY;

ADULT; AGED; CATHEPSINS; CYSTEINE ENDOPEPTIDASES; ENDOPEPTIDASES; HUMANS; KINETICS; MIDDLE AGED; SPECTROMETRY, FLUORESCENCE; SUBSTRATE SPECIFICITY; TISSUE EXTRACTS;

EID: 0032861091     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.1999.138     Document Type: Article

References (33)

1. Anastasi, A., Brown, M.A., Kembhavi, A.A., Nicklin, M.J.H., Sayers, C.A., Sunter, D.C., and Barrett, A.J. (1983). Cystatin, a protein inhibitor of cysteine proteinases. Improved purification from egg white, characterization, and detection in chicken serum. Biochem. J. 211, 129-138.
2. Barrett, A.J., and Kirschke, H. (1981). Cathepsin B, cathepsin H and cathepsin L. In: Methods in Enzymology, Vol. 80, L. Lorand, ed. (New York, USA: Academic Press), pp. 535-561.
3. Barrett, A.J., Kembhavi, A.A., Brown, M.A., Kirschke, H., Knight, C.G., Tamai, M., and Hanada, K. (1982). L-trans-Epoxysuccinylleucylamido-(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L. Biochem. J. 201, 189-198.
4. Berquin, I.M., and Sloane, B.F. (1994). Cysteine proteases and tumor progression. Perspect. Drug Discov. Design 2, 371-388.
5. Bradford, M.M. (1976). A rapid and sensitive method for the quantitation of microgramm quantities of protein utilizing the principles of protein-dye binding. Anal. Biochem. 72, 248-254.
6. Brömme, D., Steinert, A., Friebe, S., Fittkau, S., Wiederanders, B., and Kirschke, H. (1989). The specificity of bovine spleen cathepsin S: a comparison with rat liver cathepsins L and B. Biochem. J. 264, 475-481.
7. Büttner, J., Hansert, E., and Stamm, D. (1970). Auswertung, Kontrolle und Beurteilung von Meßergebnissen. In: Methoden der enzymatischen Analyse, 2. A., Vol. 1, H.-U. Bergmeyer, ed. (Weinheim/Bergstraße, Germany: Verlag Chemie), pp. 281-364.
8. Burnett, D., and Stockely, R.A. (1985). Cathepsin B-like cysteine proteinase activity in sputum and bronchoalveolar lavage samples: relationship to inflammatory cells and effects of corticosteroids and antibiotic treatment. Clin. Sci. 68, 469-474.
9. Dehrmann, F.M., Coetzer, Th.H.T., Pike, R.N., and Dennison C. (1995). Mature cathepsin L is substantially active in the ionic milieu of the extracellular medium. Arch. Biochem. Biophys. 324, 93-98.
10. Elliott, E., and Sloane, B.F. (1996). The cysteine protease cathepsin B in cancer. Perspect. Drug Discov. Design 6, 12-32.
11. European Committee for Clinical Laboratory Standards. (1986). In: Guidelines for a user laboratory to evaluate and select a kit for its own use. ECCLS document 3, ECCLS, ed. (Berlin, Germany).
12. Gabrijelcic, D., Svetic, B., Spaic, D., Skrk, J., Budihna, M., Dolenc, I., Popovic, T., Cotic, V., and Turk, V. (1992). Cathepsins B, H and L in human breast carcinoma. Eur. J. Clin. Chem. Clin. Biochem. 30, 69-74.
13. Ikeuchi, I., and Amano T. (1985). Fluorometric determination of 4-Hydroxyifosfamide in blood and urine. Chem. Pharm. Bull. 33, 2416-2420.
14. Inubushi, T., Kakegawa, H., Kishino, Y., and Katunuma, N. (1994). Specific assay method for the activities of cathepsin L-type cysteine proteinases. J. Biochem. 116, 282-284.
15. Kirschke, H., Schmidt, I., and Wiederanders, B. (1986). Cathepsin S. The cysteine proteinase from bovine lymphoid tissue is distinct from cathepsin L (EC 3.4.22.15). Biochem. J. 240, 455-459.
16. Kirschke, H., Barrett, A.J., and Rawlings, N.D. (1995). Proteinases 1:lysosomal cysteine proteinases. In: Protein Profile, Vol. 2, P. Sheterline ed. (London, England: Academic Press Ltd.), pp. 1580-1643.
17. th ICOP Conference, Vol. 13, V.K. Hopsu-Havu, M. Järvinen and H. Kirschke, eds. (Amsterdam, The Netherlands: IOS Press), pp. 479-484.
18. Knoch, H., Werle, B., Ebert, W., and Spiess, E. (1994). Imbalance between cathepsin B and cysteine proteinase inhibitors is of prognostic significance in human lung cancer. Int. J. Oncol. 5, 77-85.
19. Lah, T.T., Kokalj-Kunnovar, M., Strukelj, B., Punggercar, J., Barlic-Maganja, D., Drobnic-Kosorok, M., Kastelic, L., Babnik, J., Golouh, R., and Turk, V. (1992). Stefins and lysosomal cathepsin B, L and D in human breast carcinoma. Int. J. Cancer 50, 36-44.
20. Lesser, M., Galicki, N., Cardozo, C., and Gariola, G.C. (1989). Cathepsin L activity in alveolar macrophages of rats: response to cigarette smoke. Am. J. Respir. Cell Mol. Biol. 1, 371-376.
21. Mason, R.W., Green, G.D., and Barrett, A.J. (1985). Human liver cathepsin L. Biochem. J. 226, 233-241.
22. Murata, M., Miyashita, S., Yokoo, C., Tamai, M., Hanada, K., Hatayama, K., Towatari, T., Nikawa, T., and Katunuma, N. (1991). Novel epoxysuccinyl peptides. Selective inhibitors of cathepsin B in vitro. FEBS Lett. 280, 307-310.
23. Passing, H., and Bablok, W. (1983). A new biometrical procedure for testing the equality of measurement from two different analytical methods. Aplication of linear procedures for method comparison studies in clinical chemistry, Part I. J. Clin. Chem. Clin. Biochem. 21, 709-720.
24. Passing, H., and Bablok, W. (1984). Comparison of several regression procedures for the method comparison studies and determination of sample size. Application of linear regression procedures for method comparison studies in clinical chemistry, Part II. J. Clin. Chem. Biochem. 22, 431-445.
25. Schumacher, J., and Werle, B. (1995). Verfahren und Vorrichtung zur Bestimmung der Aktivität von Enzymen in Flüssigkeiten. German Patent no. DE 195 27 880 C1.
26. Shi, G-P., Munger, J.S., Meara, J.P., Rich, D.H., and Chapman, H.A. (1992). Molecular cloning and expression of human alveolar macrophage cathepsin S, an elastinolytic cysteine protease. J. Biol. Chem. 267, 7258-7262.
27. Turk, B., Dolenc, I., Turk, V., and Bieth, J.G. (1993). Kinetics of pH-induced inactivation of human cathepsin L. Biochem. 32, 375-380.
28. Turk, B., Dolenc, I., Zerovnik, E., Turk, D., Gubensek, F., and Turk, V. (1994). Human cathepsin B is a metastable enzyme stabilized by specific ionic interactions associated with the active site. Biochem. 33, 14800-14806.
29. Ulbricht, B., Hagmann, W., Ebert, W., and Spiess, E. (1996). Differential secretion of cathepsins B and L from normal and tumor human lung cells stimulated by 12 (S)-hydroxy-eicosatetraenoic acid. Exp. Cell Res. 226, 255-263.
30. Werle, B., Ebert, W., Klein, W., and Spiess, E. (1995). Assessment of cathepsin L activity by use of the inhibitor CA-074 compared to cathepsin B activity in human lung tumor tissue. Biol. Chem. Hoppe-Seyler 376, 157-164.
31. Werle, B., Lötterle, H., Schanzenbächer, U., Lah, T.T., Kalman, E., Kayser, K., Bülzebruck, H., Schirren, J., Krasovec, M., Kos, J., and Spiess, E. (1999). Immunochemical analysis of cathepsin B in lung tumours: an independent prognostic factor for squamous cell carcinoma patients. Br. J. Cancer (in press).
32. Yamato, S., Sugihara, H., and Shimada, K. (1990). An enzymatic assay of chloramphenicol coupled with fluorescence reaction. Chem. Pharm. Bull. 38, 2290-2292.
33. Biol. Chem., Vol. 380, pp. 1117-1120, September 1999